SEC Company Response from Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592) (ERNA) — Mar 13, 2008
Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592)
Date: March 13, 2008 · CIK: 0000748592 · Accession: 0001193125-08-054951
AI Filing Summary & Sentiment
File numbers found in text: 001-11460
Referenced dates: January 28, 2008
Show Raw Text
CORRESP 1 filename1.htm Correspondence March 13, 2008 Via Edgarlink Securities and Exchange Commission Division of Corporation Finance Mail Stop 3720 Washington, D.C. 20549 Attention: Mr. Larry Spirgel, Assistant Director Mr. Kyle Moffatt, Accounting Branch Chief Ms. Inessa Kessman, Senior Staff Accountant Re: NTN Buzztime, Inc. Form 10-K for Fiscal Year Ended December 31, 2006, filed March 16, 2007 Form 10-Q for Fiscal Quarter Ended June 30, 2007 File No. 001-11460 Dear Messrs. Spirgel, Moffatt and Ms. Kessman: We have received your comment letter dated January 28, 2008 relating to the NTN Buzztime, Inc. filings described above and we are in the process of preparing a response. We filed correspondence with you on February 5, 2008, stating that we expected to submit a response to you on or before February 18, 2008. Per a subsequent telephone conversation, we filed a correspondence with you on February 15, 2008, extending the date of our expected response until February 25, 2008. Per our telephone conversation on March 11, 2008, we now expect to submit a response to you on or before March 20, 2008. Yours very truly, /s/ Kendra Berger Kendra Berger Chief Financial Officer KB:lkw cc: Kirt Shuldberg, Heller Ehrman, LLP